Divi's Laboratories receives Rs. 570.51 Crore draft IT assessment order for FY2022-23
REGULATORY
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 21 Mar 2026, 04:17 PM IST · BSE ID: b51d2693-409d-402b-b14c-d8ee11ccc1f3
View Original BSE Filing (PDF)
💡
In Simple Terms
The government's tax department is claiming Divi's Laboratories owes Rs. 570.51 Crores in disputed taxes for FY2022-23, and the company plans to challenge this decision.
🤖 AI Summary
- Divi's Laboratories received Draft Assessment Order for FY2022-23 proposing Rs. 570.51 Crores additions
- Assistant Commissioner of Income Tax, Central Circle-2(1), Hyderabad issued order on March 20, 2026
- Additions relate to Transfer Pricing adjustments on domestic transactions and corporate tax adjustments
- Penalty proceeding under Section 270A will be initiated separately for alleged income under-reporting
- Company evaluating Draft Order and intends to file appeal within stipulated timeframe
🔢 Key Numbers — exact figures from BSE filing, not rounded
Proposed tax additions and disallowances
Rs. 570.51 Crores
Assessment Year
2023-24 (FY2022-23)
Date of Draft Order
March 20, 2026
Date of receipt
March 21, 2026
🏢 How This Affects the Company
Draft Order proposes additional income tax liability of Rs. 570.51 Crores. Final cash outflow depends on appeal outcome and settlement.
Company faces two-stage tax dispute — assessment order plus separate penalty proceeding under Section 270A for alleged under-reporting. Appeal outcome remains uncertain.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Monitor company disclosure of appeal filing and any settlement updates in subsequent BSE filings.
👤
Who Is Affected
All equity shareholders. Tax provision impact and potential cash outlay will affect consolidated financial position depending on appeal outcome.
🔍
Management Signal
Management is contesting the assessment order through formal appeal process rather than accepting the Draft Order, indicating confidence in its tax position.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Appeal filing confirmation — track BSE disclosure within statutory timeframe post-Draft Order
Income Tax Appellate Tribunal hearing outcome — monitor for settlement or order direction
FY2026 financial results — check tax provision reversal or increase based on appeal progress
MEDIUM RISK
Rs. 570.51 Crores represents material tax exposure. Two-pronged proceeding adds complexity. Appeal outcome and timeline remain uncertain.
💡 Investor Takeaway
Divi's Laboratories received a Draft Assessment Order proposing Rs. 570.51 Crores in additions for FY2022-23 on Transfer Pricing and tax adjustments. Company intends to appeal. Separate penalty proceeding under Section 270A initiated for alleged income under-reporting. Final liability contingent on appeal outcome.
⚖️ Strengths & Concerns
⚠️ Concerns
- Rs. 570.51 Crores in proposed tax additions represents material financial exposure pending appeal outcome
- Separate penalty proceeding under Section 270A compounds the tax dispute with additional compliance obligations